SOMESThesia and ALIMentation (SOMEST'ALIM)
Head and Neck Cancer
About this trial
This is an interventional basic science trial for Head and Neck Cancer focused on measuring head and neck cancer, nutrition, somesthesia
Eligibility Criteria
Inclusion Criteria:
All subjects:
- Person between 18 and 65 years
- Person having given free, informed, express written consent
- Person affiliated to a French social security system
- Person with a body mass superior to 18 kg/m².
- Person able to come once to the Institut Paul Bocuse
Patients with head and neck cancer with chemotherapy:
- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiochemotherapy or radiochemotherapy alone
Patients with head and neck cancer without chemotherapy:
- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiation therapy or radiation therapy alone
Healthy volunteers :
- Volunteer who is +/- 5 years of age relative to the patient to whom they are matched.
- Volunteer of the same sex as the patient to whom they are matched
- Volunteer with the same smoking status as the patient to whom they are matched
- Volunteer who has not had cancer within 5 years at the time of inclusion
- Volunteer with no current treatment that may affect taste and smell perception
Exclusion Criteria:
All subjects:
- Person with a known food allergy/intolerance (lactose or milk protein) or unable to consume dairy or solid products (e.g., chocolate milk pudding, chocolate jelly)
- Person with a known allergy to chili (or capsaicin)
- Person with diagnosed total ageusia
- Person with diagnosed total anosmia
- Person who has used artificial feeding within 2 months prior to inclusion.
- Person who has lost more than 10% of baseline weight in the 2 months prior to inclusion
- Person deprived of liberty or under guardianship or trusteeship.
- Pregnant or breastfeeding woman
- Person deprived of liberty by a judicial or administrative decision
- Person under guardianship or protection of vulnerable adults
- Person with trismus (reduced jaw opening or limited jaw range of motion)
- A person who is unable to extend his or her tongue
- Person who has had surgery on the mobile tongue and/or base of the tongue
- Person unable to swallow soft foods
- Person who has had or is suspected of having had Corona Virus Disease (COVID)-19 within the last 6 months.
Patients with head and neck cancer:
- Patient receiving immunotherapy
- Patient treated with surgery only.
Sites / Locations
- Service d'Oncologie médicale, Hôpital de la Croix-Rousse
- Centre de recherche de l'Institut Paul Bocuse
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
head and neck cancer patients with radiotherapy AND chemotherapy
head and neck cancer patients with radiotherapy only
healthy volunteers
patients included for a head and neck cancer and treated by radiotherapy (+/- surgery) + chemotherapy
patients included for a head and neck cancer and treated by radiotherapy (+/- surgery) without chemotherapy
healthy volunteers paired with experimental patients on age (+/- 5 years), gender, tobacco status